Statistics
Publications
82
Citations
16.5K
H-Index
41
Active since
2004
Bilal Piperdi is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in oncology, medicine, and pembrolizumab therapy.
Publications per year
2004–2023
82
82
Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
Luis Paz‐Ares, Alexander Luft, David Vicente et al. · New England Journal of Medicine · 2018 · 3.6K citations · Full text
Medicine, Oncology, Pharmacotherapy +17
Luis Paz‐Ares, David Vicente, Ali Tafreshi et al. · Journal of Thoracic Oncology · 2020 · 645 citations · Full text
Medicine, Oncology, Pharmacology +14
Evan Alley, Juanita Lopez, Armando Santoro et al. · The Lancet Oncology · 2017 · 492 citations
Medicine, Oncology, Pharmacology +15
1–5 of 82